MedTrace Logo

Music-based Intervention for the Reduction of Pain

NCT02991014 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-04-28

No results posted yet for this study

Summary

This study aims to compare the impact of listening to frequency-modulated music vs. non-modulated music (both researcher-selected), and to test whether there are differential effects on pain and stress perception. Further, these two conditions will be compared to a third condition, in which participants will be exposed to self-selected non-modulated music. It is hypothesized that both researcher-selected frequency-modulated music and self-selected non-modulated music result in stronger decreases in stress and pain compared to researcher-selected non-modulated music, while it is expected that there will be no differences in researcher-selected frequency-modulated music and self-selected non-modulated music. The intervention consists of ten sessions of music listening in the course of three consecutive weeks.

Conditions

  • Pain Perception
  • Autonomic Nervous System Functioning

Interventions

BEHAVIORAL

researcher-selected frequency-modulated music

Music pieces have been selected in advance by the researchers. Furthermore, musical frequencies have been artificially modulated.

BEHAVIORAL

researcher-selected non-modulated music

The same music pieces as in the active comparator arm have been selected in advance by the researchers, but no artificial frequency modulation.

BEHAVIORAL

participant-selected non-modulated music

Participants bring their own choice of personally preferred music pieces and listen to them during the intervention sessions. There is no frequency modulation in this condition.

Sponsors & Collaborators

  • University of Vienna

    lead OTHER

Principal Investigators

  • Urs Nater, PhD · University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02991014 on ClinicalTrials.gov